NCT06051721 - A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants with Generalized Anxiety Disorder (GAD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

February 28, 2025

Conditions

Generalized Anxiety Disorder

Interventions

DRUG

CYB004

CYB004 is a synthetic deuterated N, N-Dimethyltryptamine (DMT) analog.

BEHAVIORAL

Psychotherapy

Manualized psychotherapy (called EMBARK) performed by facilitators

Trial Locations (4)

RECRUITING

iResearch Atlanta, Decatur

RECRUITING

CenExel ACMR, Atlanta

RECRUITING

Innovative Clinical Research, Inc., Miami Lakes

RECRUITING

Cedar Clinical Research, Murray